# FDA Inspection 1258621 - Department of the Air Force, 11th Medical Group - December 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-11th-medical-group/4388b729-c150-410b-a984-db4824d1addf
Source feed: FDA_Inspections

> FDA Inspection 1258621 for Department of the Air Force, 11th Medical Group on December 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258621
- Company Name: Department of the Air Force, 11th Medical Group
- Inspection Date: 2024-12-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258621 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-11th-medical-group/a11672dc-3a2a-4435-b6f1-907e0fe3d3fe)
- [FDA Inspection 1106849 - 2019-09-24](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-11th-medical-group/60950932-d858-47a1-88eb-d15ebabdb69d)
- [FDA Inspection 1010172 - 2017-03-21](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-11th-medical-group/8d8e81ad-2854-452d-96b8-ddb9d9020ab4)
- [FDA Inspection 921186 - 2015-04-08](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-11th-medical-group/584f53ca-99ab-4bfb-a31c-aee1a457e7f2)
- [FDA Inspection 838902 - 2013-06-27](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-11th-medical-group/3f3801b8-27e1-4b0d-ba76-df000f878906)

Company: https://www.keypedia.com/companies/department-of-the-air-force-11th-medical-group/c4905dd7-3230-4905-9b62-792192eec6a8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
